NCT05539144Completed
A New Delineation Approach for Oral Cavity, Oropharynx, Larynx and Hypopharynx in IMRT for Head and Neck Cancer
A New Delineation Approach for Oral Cavity, Oropharynx, Larynx and Hypopharynx in Intensity-modulated Radiation Treatment for Head and Neck Cancer
Source: ClinicalTrials.gov · Last updated 17 May 2024
Brief summary (registry, in English)
The investigators tries a new method to delineating the oral cavity, oropharynx, larynx and hypopharynx, and use the head-and-neck region to test whether the method can to create a good IMRT plan, and alleviate the oral radiation injury, reduce the incidence of adverse reactions.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 8 (actual)
- First submitted
- 5 Sept 2022
- Start date
- 11 Nov 2021
- Primary completion date
- 11 Dec 2022
- Lead sponsor
- Hebei Provincial Hospital of Traditional Chinese Medicine
- Diseases
- Head and neck cancer, Childhood cancers
- NCT number
- NCT05539144
What you commit to
- Study type: Interventional
- Participants enrolled: 8
- From 11 Nov 2021 to the primary completion date, 11 Dec 2022
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- \-
Who the study is looking for
- \- patients with previously untreated of the head and neck cancer who received definitive IMRT at our institution
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of Radiotherapy, Hebei Province Hospital of Chinese Medicine Coordinator of this site? Confirm its status | Shijiazhuang | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.